November 25, 2022
AbbVie on November 24 rolled out a new pediatric granule form of its hepatitis C drug Maviret (glecaprevir + pibrentasvir) in Japan, making it the first direct-acting antiviral agent available in the country to treat chronic hepatitis C in children...read more